Shots: Pear Therapeutics launches Somryst as the first PDT intended for use in the treatment of patients with chronic insomnia aged > 22yrs. It addresses the issues of chronic insomnia […]readmore
Tags : Launches
Shots: Qiagen has initiated the commercialization of the portable digital QIAreach SARS-CoV-2 antigen test in the US that can be used by laboratories to detect active infections in 2-15mins. The […]readmore
Shots: The integration of real-time CGM data into the smart insulin pen app follows the acquisition of Companion Medical’s InPen to the Medtronic portfolio, as of Sept’2020 The integrated system […]readmore
Shots: Sanofi’s Tetraxim combines four vaccines into one and provides protection against four diseases – Diphtheria, Pertussis, Tetanus and Polio. The launch reduces the number of injections, increases comfort, and […]readmore
Shots: The company has initiated a controlled launch of the ACURATE neo2 Aortic Valve System in the EU. The ACURATE neo2 valve system has expanded its indication for patients with […]readmore
Shots: Royal Philips has expanded its peripheral vascular disease portfolio with the launch of the QuickClear mechanical thrombectomy system. The system features an all-in-one aspiration pump and catheter for the […]readmore
Shots: Accord launches Zercepac as s a biosimilar referencing Herceptin in the UK, following the EC’s approval in Jul’2020. The EC’s approval is based on a series of robust studies […]readmore
Shots: Roche has launched Elecsys Anti-SARS-CoV-2 S Ab for markets accepting the CE Mark. The company has filed for US FDA’s EUA The test can quantitatively measure the level of […]readmore
Shots: The robotic digital microscope enables surgeons to execute precision movements in neurosurgery, spine, and ear, nose, and throat operations, through a multi-axis robotic arm. The platform also offer potential […]readmore
Shots: Cadila has launched the adalimumab biosimilar under the brand name Cadalimab, referencing AbbVie’s Humira which is used to treat RA,PsA, AS and psoriasis The launch strengthens Cadila’s biosimilar portfolio […]readmore